Investor’s Toolkit: Key Ratios for Assessing Universal Technical Institute Inc (UTI)’s Performance

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

Universal Technical Institute Inc (NYSE: UTI) closed the day trading at $15.19 down -8.99% from the previous closing price of $16.69. In other words, the price has decreased by -$8.99 from its previous closing price. On the day, 1.69 million shares were traded. UTI stock price reached its highest trading level at $16.1 during the session, while it also had its lowest trading level at $14.144.


For a better understanding of UTI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.03. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 1.39 whereas as Long-Term Debt/Eq ratio is at 1.28.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Northland Capital on January 10, 2024, initiated with a Outperform rating and assigned the stock a target price of $16.

On July 12, 2022, Rosenblatt started tracking the stock assigning a Buy rating and target price of $11.Rosenblatt initiated its Buy rating on July 12, 2022, with a $11 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 26 ’24 when Sanchez Loretta Lydia sold 8,719 shares for $15.07 per share. The transaction valued at 131,381 led to the insider holds 20,000 shares of the business.

Coliseum Capital Management, L sold 3,956,427 shares of UTI for $59,544,226 on Feb 15 ’24. The Director now owns 9,334,215 shares after completing the transaction at $15.05 per share. On Dec 14 ’23, another insider, Anderson Troy R, who serves as the EVP and CFO of the company, sold 7,173 shares for $10.94 each. As a result, the insider received 78,473 and left with 87,442 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTI now has a Market Capitalization of 896787200 and an Enterprise Value of 1023675840. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 42.49, and their Forward P/E ratio for the next fiscal year is 16.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.20 while its Price-to-Book (P/B) ratio in mrq is 3.51. Its current Enterprise Value per Revenue stands at 1.5 whereas that against EBITDA is 15.479.

Stock Price History:

Over the past 52 weeks, UTI has reached a high of $17.09, while it has fallen to a 52-week low of $5.63. The 50-Day Moving Average of the stock is 1.03%, while the 200-Day Moving Average is calculated to be 30.17%.

Shares Statistics:

Over the past 3-months, UTI traded about 587.00K shares per day on average, while over the past 10 days, UTI traded about 633250 shares per day. A total of 53.73M shares are outstanding, with a floating share count of 49.87M. Insiders hold about 7.20% of the company’s shares, while institutions hold 70.73% stake in the company. Shares short for UTI as of 1713139200 were 1471487 with a Short Ratio of 2.51, compared to 1710460800 on 1241643. Therefore, it implies a Short% of Shares Outstanding of 1471487 and a Short% of Float of 3.7600000000000002.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 3.72.

Most Popular

[the_ad id="945"]